John B. Ketchum

Insider Reports History

Entity
Individual
Location
Tango Therapeutics, Inc., 201 Brookline Ave., Suite 901, Boston, MA
Signature
/s/ Douglas Barry, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John B. Ketchum:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Director Common Stock 14.7K $112K $7.61 Jun 5, 2024 Direct
Tango Therapeutics, Inc. Director Stock Option (Right to Buy) 28.1K Jun 5, 2024 Direct

Insider Reports Filed by John B. Ketchum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNGX Tango Therapeutics, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
TNGX Tango Therapeutics, Inc. Aug 29, 2023 2 $0 4 Aug 31, 2023 Director
TNGX Tango Therapeutics, Inc. Aug 29, 2023 0 $0 3 Aug 31, 2023 Director